Mangoceuticals Inc (MGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 163 | 214 | 244 | 245 | 141 |
| Cost of Goods | 93 | 67 | 102 | 101 | 54 |
| Gross Profit | 70 | 147 | 143 | 145 | 87 |
| Operating Expenses | 2,332 | 2,582 | 3,980 | 2,045 | 2,434 |
| Operating Income | -2,169 | -2,368 | -2,568 | -1,800 | -2,292 |
| Interest Expense | 223 | 0 | 13 | 0 | -8 |
| Other Income | 0 | 0 | 13 | 0 | 0 |
| Pre-tax Income | -2,391 | -2,368 | -2,568 | -1,800 | -2,284 |
| Net Income Continuous | -2,391 | -2,368 | -2,568 | -1,800 | -2,284 |
| Net Income | $-2,391 | $-2,368 | $-2,568 | $-1,800 | $-2,284 |
| EPS Basic Total Ops | -1.37 | -1.50 | -1.33 | -1.70 | -2.10 |
| EPS Basic Continuous Ops | -1.37 | -1.50 | -1.30 | -1.69 | -2.17 |
| EPS Diluted Total Ops | -1.37 | -1.50 | -1.33 | -1.70 | -2.10 |
| EPS Diluted Continuous Ops | -1.37 | -1.50 | -1.30 | -1.69 | -2.17 |
| EPS Diluted Before Non-Recurring Items | -1.35 | -1.50 | -1.95 | N/A | N/A |
| EBITDA(a) | $-1,914 | $-2,361 | $-3,730 | $-1,793 | $-2,286 |